Literature DB >> 9725226

The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1.

D D Donaldson1, M J Whitters, L J Fitz, T Y Neben, H Finnerty, S L Henderson, R M O'Hara, D R Beier, K J Turner, C R Wood, M Collins.   

Abstract

Two components of a receptor complex for IL-13, the IL-4R and a low affinity IL-13-binding chain, IL-13R alpha 1, have been cloned in mice and humans. An additional high affinity binding chain for IL-13, IL-13R alpha 2, has been described in humans. We isolated a cDNA from the thymus that encodes the murine orthologue of the human IL-13R alpha 2. The predicted protein sequence of murine IL-13R alpha 2 (mIL-13R alpha 2) has 59% overall identity to human IL-13R alpha 2 and is closely related to the murine low affinity IL-13-binding subunit, IL-13R alpha 1. The genes for both mIL-13-binding chains map to the X chromosome. A specific interaction between mIL-13R alpha 2.Fc protein and IL-13 was demonstrated by surface plasmon resonance using a BIACORE instrument. Ba/F3 cells that were transfected with mIL-13R alpha 2 expressed 5000 molecules per cell and bound IL-13 with a single Kd of 0.5 to 1.2 nM. However, these cells did not proliferate in response to IL-13, and the IL-4 dose response was unaffected by high concentrations of IL-13. In contrast, the expression of mIL-13R alpha 1 by Ba/F3 cells resulted in a sensitive proliferative response to IL-13. Consistent with its lower affinity for IL-13, IL-13R alpha 1.Fc was 100-fold less effective than IL-13R alpha 2.Fc in neutralizing IL-13 in vitro. These results show that mIL-13R alpha 2 and mIL-13R alpha 1 are not functionally equivalent and predict distinct roles for each polypeptide in IL-13R complex formation and in the modulation of IL-13 signal transduction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725226

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  92 in total

Review 1.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

2.  Interleukin-13 receptor subunit alpha-2 is a target of progesterone receptor and steroid receptor coactivator-1 in the mouse uterus†.

Authors:  Ryan M Marquardt; Kevin Lee; Tae Hoon Kim; Brandon Lee; Francesco J DeMayo; Jae-Wook Jeong
Journal:  Biol Reprod       Date:  2020-10-05       Impact factor: 4.285

Review 3.  Negative Regulation of Type 2 Immunity.

Authors:  Dimitri A de Kouchkovsky; Sourav Ghosh; Carla V Rothlin
Journal:  Trends Immunol       Date:  2017-01-09       Impact factor: 16.687

Review 4.  Transgenic modelling of cytokine polarization in the lung.

Authors:  Charles S Dela Cruz; Min-Jong Kang; Won-Kyung Cho; Chun Geun Lee
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

5.  Regulation of IFN-γ by IL-13 dictates susceptibility to secondary postinfluenza MRSA pneumonia.

Authors:  Agnieszka Rynda-Apple; Ann Harmsen; Anfin S Erickson; Kyle Larson; Rachelle V Morton; Laura E Richert; Allen G Harmsen
Journal:  Eur J Immunol       Date:  2014-09-01       Impact factor: 5.532

6.  IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice.

Authors:  Weiguo Chen; Umasundari Sivaprasad; Yasuhiro Tabata; Aaron M Gibson; Matthew T Stier; Fred D Finkelman; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

7.  Molecular cloning of the rat IL-13 alpha 2 receptor cDNA and its expression in rat tissues.

Authors:  An-Hua Wu; Walter C Low
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

8.  Restoration of tumor immunosurveillance via targeting of interleukin-13 receptor-alpha 2.

Authors:  Stefan Fichtner-Feigl; Masaki Terabe; Atsushi Kitani; Cheryl A Young; Ivan Fuss; Edward K Geissler; Hans-Jürgen Schlitt; Jay A Berzofsky; Warren Strober
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

9.  Elevated IL-13Ralpha2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway.

Authors:  Debasmita Mandal; Alan D Levine
Journal:  Inflamm Bowel Dis       Date:  2010-05       Impact factor: 5.325

Review 10.  Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.